Loading...

Home
ETF
EXOZ

EXOZ

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

EXOZ News

MDB Capital Holdings Earnings Outlook

Apr 07 2026Yahoo Finance

EXoZymes Inc Earnings Report Analysis and Outlook

Apr 01 2026Yahoo Finance

eXoZymes Reports Increased FY Net Loss and Rising Expenses

Mar 31 2026seekingalpha

Monday 7/7 Insider Buying Report: EXOZ, IAF

Jul 07 2025NASDAQ.COM

Bringing clarity and precision to the cell-free space by introducing exozymes

Apr 21 2025Newsfilter

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

Apr 10 2025Newsfilter

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

Apr 02 2025Newsfilter

eXoZymes Inc trading resumes

Mar 17 2025Business Insider

eXoZymes Inc trading halted, volatility trading pause

Mar 17 2025Business Insider

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.

Feb 21 2025Newsfilter

eXoZymes president, chairman Hayat transitions out of roles

Feb 21 2025Business Insider